nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ORM1—Vismodegib—skin cancer	0.238	0.3	CbGbCtD
Trazodone—ORM1—Vemurafenib—skin cancer	0.188	0.237	CbGbCtD
Trazodone—ABCB1—Vismodegib—skin cancer	0.0524	0.0659	CbGbCtD
Trazodone—CYP3A4—Temozolomide—skin cancer	0.0453	0.057	CbGbCtD
Trazodone—CYP3A4—Imiquimod—skin cancer	0.0453	0.057	CbGbCtD
Trazodone—CYP2D6—Vemurafenib—skin cancer	0.039	0.0491	CbGbCtD
Trazodone—CYP3A4—Vismodegib—skin cancer	0.0314	0.0395	CbGbCtD
Trazodone—CYP3A7—Docetaxel—skin cancer	0.0291	0.0366	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0291	0.0366	CbGbCtD
Trazodone—ABCB1—Dactinomycin—skin cancer	0.0275	0.0346	CbGbCtD
Trazodone—CYP3A4—Vemurafenib—skin cancer	0.0248	0.0312	CbGbCtD
Trazodone—CYP3A5—Docetaxel—skin cancer	0.0218	0.0275	CbGbCtD
Trazodone—ABCB1—Docetaxel—skin cancer	0.0142	0.0179	CbGbCtD
Trazodone—CYP3A4—Docetaxel—skin cancer	0.00851	0.0107	CbGbCtD
Trazodone—HRH1—nose—skin cancer	0.00285	0.16	CbGeAlD
Trazodone—HTR2A—hindlimb—skin cancer	0.00112	0.063	CbGeAlD
Trazodone—HTR2A—appendage—skin cancer	0.000962	0.0541	CbGeAlD
Trazodone—HTR2A—nerve—skin cancer	0.000682	0.0383	CbGeAlD
Trazodone—HTR2A—endothelium—skin cancer	0.000581	0.0326	CbGeAlD
Trazodone—HTR2A—blood vessel—skin cancer	0.000536	0.0301	CbGeAlD
Trazodone—Anxiety—Imiquimod—skin cancer	0.000512	0.00273	CcSEcCtD
Trazodone—Discomfort—Imiquimod—skin cancer	0.000508	0.00271	CcSEcCtD
Trazodone—Dry mouth—Imiquimod—skin cancer	0.000503	0.00268	CcSEcCtD
Trazodone—Decreased appetite—Vemurafenib—skin cancer	0.000502	0.00268	CcSEcCtD
Trazodone—Fatigue—Vemurafenib—skin cancer	0.000498	0.00266	CcSEcCtD
Trazodone—Constipation—Vemurafenib—skin cancer	0.000494	0.00263	CcSEcCtD
Trazodone—Oedema—Imiquimod—skin cancer	0.000493	0.00263	CcSEcCtD
Trazodone—Lightheadedness—Docetaxel—skin cancer	0.000492	0.00263	CcSEcCtD
Trazodone—Hypoaesthesia—Bleomycin—skin cancer	0.00049	0.00261	CcSEcCtD
Trazodone—Shock—Imiquimod—skin cancer	0.000485	0.00258	CcSEcCtD
Trazodone—Tachycardia—Imiquimod—skin cancer	0.000481	0.00256	CcSEcCtD
Trazodone—Pollakiuria—Temozolomide—skin cancer	0.00048	0.00256	CcSEcCtD
Trazodone—Erectile dysfunction—Temozolomide—skin cancer	0.000478	0.00255	CcSEcCtD
Trazodone—Hyperhidrosis—Imiquimod—skin cancer	0.000476	0.00254	CcSEcCtD
Trazodone—Photosensitivity reaction—Temozolomide—skin cancer	0.000474	0.00253	CcSEcCtD
Trazodone—Weight increased—Temozolomide—skin cancer	0.000473	0.00252	CcSEcCtD
Trazodone—Weight decreased—Temozolomide—skin cancer	0.00047	0.0025	CcSEcCtD
Trazodone—Anorexia—Imiquimod—skin cancer	0.00047	0.0025	CcSEcCtD
Trazodone—HTR2B—skin of body—skin cancer	0.000464	0.0261	CbGeAlD
Trazodone—HRH1—nipple—skin cancer	0.000464	0.0261	CbGeAlD
Trazodone—Flushing—Bleomycin—skin cancer	0.000457	0.00244	CcSEcCtD
Trazodone—Body temperature increased—Vemurafenib—skin cancer	0.000457	0.00243	CcSEcCtD
Trazodone—ADRA2A—nipple—skin cancer	0.000455	0.0256	CbGeAlD
Trazodone—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000449	0.00239	CcSEcCtD
Trazodone—Deafness—Docetaxel—skin cancer	0.000447	0.00238	CcSEcCtD
Trazodone—Insomnia—Imiquimod—skin cancer	0.000446	0.00238	CcSEcCtD
Trazodone—Paraesthesia—Imiquimod—skin cancer	0.000442	0.00236	CcSEcCtD
Trazodone—Chills—Bleomycin—skin cancer	0.000442	0.00236	CcSEcCtD
Trazodone—Cardiac failure congestive—Docetaxel—skin cancer	0.000441	0.00235	CcSEcCtD
Trazodone—Dyspnoea—Imiquimod—skin cancer	0.000439	0.00234	CcSEcCtD
Trazodone—Somnolence—Imiquimod—skin cancer	0.000438	0.00234	CcSEcCtD
Trazodone—Photosensitivity reaction—Fluorouracil—skin cancer	0.000437	0.00233	CcSEcCtD
Trazodone—Alopecia—Bleomycin—skin cancer	0.000435	0.00232	CcSEcCtD
Trazodone—ORM1—female reproductive system—skin cancer	0.000429	0.0241	CbGeAlD
Trazodone—Decreased appetite—Imiquimod—skin cancer	0.000428	0.00228	CcSEcCtD
Trazodone—Flushing—Dactinomycin—skin cancer	0.000426	0.00227	CcSEcCtD
Trazodone—Hypersensitivity—Vemurafenib—skin cancer	0.000426	0.00227	CcSEcCtD
Trazodone—Fatigue—Imiquimod—skin cancer	0.000425	0.00226	CcSEcCtD
Trazodone—Atrial fibrillation—Docetaxel—skin cancer	0.000422	0.00225	CcSEcCtD
Trazodone—Visual disturbance—Docetaxel—skin cancer	0.000422	0.00225	CcSEcCtD
Trazodone—Pain—Imiquimod—skin cancer	0.000421	0.00225	CcSEcCtD
Trazodone—Acute coronary syndrome—Fluorouracil—skin cancer	0.000421	0.00224	CcSEcCtD
Trazodone—Myocardial infarction—Fluorouracil—skin cancer	0.000418	0.00223	CcSEcCtD
Trazodone—Asthenia—Vemurafenib—skin cancer	0.000415	0.00221	CcSEcCtD
Trazodone—Hallucination—Temozolomide—skin cancer	0.000414	0.0022	CcSEcCtD
Trazodone—Hypoaesthesia—Temozolomide—skin cancer	0.000414	0.0022	CcSEcCtD
Trazodone—Chills—Dactinomycin—skin cancer	0.000412	0.0022	CcSEcCtD
Trazodone—Pruritus—Vemurafenib—skin cancer	0.000409	0.00218	CcSEcCtD
Trazodone—Lethargy—Docetaxel—skin cancer	0.000408	0.00217	CcSEcCtD
Trazodone—Alopecia—Dactinomycin—skin cancer	0.000406	0.00216	CcSEcCtD
Trazodone—Feeling abnormal—Imiquimod—skin cancer	0.000406	0.00216	CcSEcCtD
Trazodone—ADRA1A—epithelium—skin cancer	0.000403	0.0227	CbGeAlD
Trazodone—Gastrointestinal pain—Imiquimod—skin cancer	0.000403	0.00215	CcSEcCtD
Trazodone—Hyponatraemia—Docetaxel—skin cancer	0.000401	0.00214	CcSEcCtD
Trazodone—Visual impairment—Temozolomide—skin cancer	0.000401	0.00214	CcSEcCtD
Trazodone—Ill-defined disorder—Bleomycin—skin cancer	0.000398	0.00212	CcSEcCtD
Trazodone—Anaemia—Bleomycin—skin cancer	0.000396	0.00211	CcSEcCtD
Trazodone—Diarrhoea—Vemurafenib—skin cancer	0.000395	0.00211	CcSEcCtD
Trazodone—Migraine—Docetaxel—skin cancer	0.000393	0.0021	CcSEcCtD
Trazodone—Urticaria—Imiquimod—skin cancer	0.000391	0.00209	CcSEcCtD
Trazodone—Body temperature increased—Imiquimod—skin cancer	0.00039	0.00208	CcSEcCtD
Trazodone—Abdominal pain—Imiquimod—skin cancer	0.00039	0.00208	CcSEcCtD
Trazodone—Tinnitus—Temozolomide—skin cancer	0.000388	0.00207	CcSEcCtD
Trazodone—Malaise—Bleomycin—skin cancer	0.000387	0.00206	CcSEcCtD
Trazodone—HTR2C—female reproductive system—skin cancer	0.000386	0.0217	CbGeAlD
Trazodone—Flushing—Temozolomide—skin cancer	0.000386	0.00206	CcSEcCtD
Trazodone—HTR2A—neck—skin cancer	0.000383	0.0215	CbGeAlD
Trazodone—Dizziness—Vemurafenib—skin cancer	0.000382	0.00204	CcSEcCtD
Trazodone—Hypoaesthesia—Fluorouracil—skin cancer	0.000381	0.00203	CcSEcCtD
Trazodone—Ataxia—Docetaxel—skin cancer	0.000376	0.002	CcSEcCtD
Trazodone—Chills—Temozolomide—skin cancer	0.000373	0.00199	CcSEcCtD
Trazodone—Ill-defined disorder—Dactinomycin—skin cancer	0.000371	0.00198	CcSEcCtD
Trazodone—Anaemia—Dactinomycin—skin cancer	0.00037	0.00197	CcSEcCtD
Trazodone—Vomiting—Vemurafenib—skin cancer	0.000367	0.00196	CcSEcCtD
Trazodone—Alopecia—Temozolomide—skin cancer	0.000367	0.00196	CcSEcCtD
Trazodone—SLC6A4—female reproductive system—skin cancer	0.000366	0.0206	CbGeAlD
Trazodone—Chest pain—Bleomycin—skin cancer	0.000365	0.00195	CcSEcCtD
Trazodone—Myalgia—Bleomycin—skin cancer	0.000365	0.00195	CcSEcCtD
Trazodone—Orthostatic hypotension—Docetaxel—skin cancer	0.000365	0.00195	CcSEcCtD
Trazodone—Rash—Vemurafenib—skin cancer	0.000364	0.00194	CcSEcCtD
Trazodone—Dermatitis—Vemurafenib—skin cancer	0.000364	0.00194	CcSEcCtD
Trazodone—Hypersensitivity—Imiquimod—skin cancer	0.000363	0.00194	CcSEcCtD
Trazodone—HTR2B—female reproductive system—skin cancer	0.000363	0.0204	CbGeAlD
Trazodone—Headache—Vemurafenib—skin cancer	0.000362	0.00193	CcSEcCtD
Trazodone—Discomfort—Bleomycin—skin cancer	0.000361	0.00192	CcSEcCtD
Trazodone—Malaise—Dactinomycin—skin cancer	0.000361	0.00192	CcSEcCtD
Trazodone—Dysgeusia—Temozolomide—skin cancer	0.000354	0.00189	CcSEcCtD
Trazodone—Asthenia—Imiquimod—skin cancer	0.000354	0.00188	CcSEcCtD
Trazodone—Confusional state—Bleomycin—skin cancer	0.000353	0.00188	CcSEcCtD
Trazodone—ABCB1—blood vessel—skin cancer	0.000351	0.0197	CbGeAlD
Trazodone—Oedema—Bleomycin—skin cancer	0.00035	0.00187	CcSEcCtD
Trazodone—Back pain—Temozolomide—skin cancer	0.00035	0.00187	CcSEcCtD
Trazodone—Pruritus—Imiquimod—skin cancer	0.000349	0.00186	CcSEcCtD
Trazodone—Nausea—Vemurafenib—skin cancer	0.000343	0.00183	CcSEcCtD
Trazodone—Arrhythmia—Fluorouracil—skin cancer	0.000342	0.00182	CcSEcCtD
Trazodone—Vision blurred—Temozolomide—skin cancer	0.000341	0.00182	CcSEcCtD
Trazodone—Myalgia—Dactinomycin—skin cancer	0.000341	0.00182	CcSEcCtD
Trazodone—Tremor—Temozolomide—skin cancer	0.000339	0.00181	CcSEcCtD
Trazodone—Alopecia—Fluorouracil—skin cancer	0.000338	0.0018	CcSEcCtD
Trazodone—Diarrhoea—Imiquimod—skin cancer	0.000337	0.0018	CcSEcCtD
Trazodone—Discomfort—Dactinomycin—skin cancer	0.000336	0.00179	CcSEcCtD
Trazodone—Ill-defined disorder—Temozolomide—skin cancer	0.000336	0.00179	CcSEcCtD
Trazodone—Anaemia—Temozolomide—skin cancer	0.000334	0.00178	CcSEcCtD
Trazodone—Anorexia—Bleomycin—skin cancer	0.000334	0.00178	CcSEcCtD
Trazodone—Agitation—Temozolomide—skin cancer	0.000332	0.00177	CcSEcCtD
Trazodone—HRH1—connective tissue—skin cancer	0.000329	0.0185	CbGeAlD
Trazodone—Hypotension—Bleomycin—skin cancer	0.000327	0.00174	CcSEcCtD
Trazodone—Oedema—Dactinomycin—skin cancer	0.000326	0.00174	CcSEcCtD
Trazodone—Malaise—Temozolomide—skin cancer	0.000326	0.00174	CcSEcCtD
Trazodone—Dizziness—Imiquimod—skin cancer	0.000326	0.00174	CcSEcCtD
Trazodone—Vertigo—Temozolomide—skin cancer	0.000325	0.00173	CcSEcCtD
Trazodone—ADRA2A—connective tissue—skin cancer	0.000323	0.0182	CbGeAlD
Trazodone—HTR2C—head—skin cancer	0.000322	0.0181	CbGeAlD
Trazodone—Palpitations—Temozolomide—skin cancer	0.00032	0.0017	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000319	0.0017	CcSEcCtD
Trazodone—Paraesthesia—Bleomycin—skin cancer	0.000314	0.00168	CcSEcCtD
Trazodone—Weight increased—Docetaxel—skin cancer	0.000314	0.00168	CcSEcCtD
Trazodone—Vision blurred—Fluorouracil—skin cancer	0.000314	0.00167	CcSEcCtD
Trazodone—Vomiting—Imiquimod—skin cancer	0.000313	0.00167	CcSEcCtD
Trazodone—Weight decreased—Docetaxel—skin cancer	0.000312	0.00167	CcSEcCtD
Trazodone—Hypertension—Temozolomide—skin cancer	0.000312	0.00167	CcSEcCtD
Trazodone—HRH1—epithelium—skin cancer	0.000312	0.0175	CbGeAlD
Trazodone—Dyspnoea—Bleomycin—skin cancer	0.000312	0.00166	CcSEcCtD
Trazodone—Anorexia—Dactinomycin—skin cancer	0.000311	0.00166	CcSEcCtD
Trazodone—Rash—Imiquimod—skin cancer	0.000311	0.00166	CcSEcCtD
Trazodone—ADRA1A—lymphoid tissue—skin cancer	0.000311	0.0175	CbGeAlD
Trazodone—Dermatitis—Imiquimod—skin cancer	0.00031	0.00165	CcSEcCtD
Trazodone—Headache—Imiquimod—skin cancer	0.000309	0.00165	CcSEcCtD
Trazodone—Anaemia—Fluorouracil—skin cancer	0.000308	0.00164	CcSEcCtD
Trazodone—Myalgia—Temozolomide—skin cancer	0.000308	0.00164	CcSEcCtD
Trazodone—Arthralgia—Temozolomide—skin cancer	0.000308	0.00164	CcSEcCtD
Trazodone—Anxiety—Temozolomide—skin cancer	0.000307	0.00164	CcSEcCtD
Trazodone—SLC6A4—head—skin cancer	0.000306	0.0172	CbGeAlD
Trazodone—Discomfort—Temozolomide—skin cancer	0.000304	0.00162	CcSEcCtD
Trazodone—Decreased appetite—Bleomycin—skin cancer	0.000304	0.00162	CcSEcCtD
Trazodone—Acute coronary syndrome—Docetaxel—skin cancer	0.000304	0.00162	CcSEcCtD
Trazodone—HTR2B—head—skin cancer	0.000303	0.017	CbGeAlD
Trazodone—Myocardial infarction—Docetaxel—skin cancer	0.000302	0.00161	CcSEcCtD
Trazodone—Dry mouth—Temozolomide—skin cancer	0.000301	0.00161	CcSEcCtD
Trazodone—Jaundice—Docetaxel—skin cancer	0.0003	0.0016	CcSEcCtD
Trazodone—Pain—Bleomycin—skin cancer	0.000299	0.0016	CcSEcCtD
Trazodone—Confusional state—Temozolomide—skin cancer	0.000298	0.00159	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000297	0.00159	CcSEcCtD
Trazodone—Oedema—Temozolomide—skin cancer	0.000295	0.00157	CcSEcCtD
Trazodone—Nausea—Imiquimod—skin cancer	0.000293	0.00156	CcSEcCtD
Trazodone—Feeling abnormal—Bleomycin—skin cancer	0.000288	0.00154	CcSEcCtD
Trazodone—Hyperhidrosis—Temozolomide—skin cancer	0.000285	0.00152	CcSEcCtD
Trazodone—Chest pain—Fluorouracil—skin cancer	0.000284	0.00151	CcSEcCtD
Trazodone—Myalgia—Fluorouracil—skin cancer	0.000284	0.00151	CcSEcCtD
Trazodone—Decreased appetite—Dactinomycin—skin cancer	0.000284	0.00151	CcSEcCtD
Trazodone—Fatigue—Dactinomycin—skin cancer	0.000281	0.0015	CcSEcCtD
Trazodone—Anorexia—Temozolomide—skin cancer	0.000281	0.0015	CcSEcCtD
Trazodone—Discomfort—Fluorouracil—skin cancer	0.00028	0.00149	CcSEcCtD
Trazodone—Pain—Dactinomycin—skin cancer	0.000279	0.00149	CcSEcCtD
Trazodone—Urticaria—Bleomycin—skin cancer	0.000278	0.00148	CcSEcCtD
Trazodone—Body temperature increased—Bleomycin—skin cancer	0.000277	0.00148	CcSEcCtD
Trazodone—Hypoaesthesia—Docetaxel—skin cancer	0.000275	0.00147	CcSEcCtD
Trazodone—HTR2A—connective tissue—skin cancer	0.000275	0.0154	CbGeAlD
Trazodone—Confusional state—Fluorouracil—skin cancer	0.000274	0.00146	CcSEcCtD
Trazodone—Oedema—Fluorouracil—skin cancer	0.000272	0.00145	CcSEcCtD
Trazodone—HTR1A—head—skin cancer	0.000271	0.0153	CbGeAlD
Trazodone—HRH1—mammalian vulva—skin cancer	0.000271	0.0152	CbGeAlD
Trazodone—Feeling abnormal—Dactinomycin—skin cancer	0.000269	0.00143	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000269	0.00143	CcSEcCtD
Trazodone—Insomnia—Temozolomide—skin cancer	0.000267	0.00142	CcSEcCtD
Trazodone—Gastrointestinal pain—Dactinomycin—skin cancer	0.000267	0.00142	CcSEcCtD
Trazodone—Visual impairment—Docetaxel—skin cancer	0.000266	0.00142	CcSEcCtD
Trazodone—ADRA2A—mammalian vulva—skin cancer	0.000266	0.015	CbGeAlD
Trazodone—Tachycardia—Fluorouracil—skin cancer	0.000266	0.00142	CcSEcCtD
Trazodone—Paraesthesia—Temozolomide—skin cancer	0.000265	0.00141	CcSEcCtD
Trazodone—Dyspnoea—Temozolomide—skin cancer	0.000263	0.0014	CcSEcCtD
Trazodone—Somnolence—Temozolomide—skin cancer	0.000263	0.0014	CcSEcCtD
Trazodone—HTR2A—epithelium—skin cancer	0.000261	0.0147	CbGeAlD
Trazodone—Anorexia—Fluorouracil—skin cancer	0.000259	0.00138	CcSEcCtD
Trazodone—Body temperature increased—Dactinomycin—skin cancer	0.000258	0.00138	CcSEcCtD
Trazodone—Abdominal pain—Dactinomycin—skin cancer	0.000258	0.00138	CcSEcCtD
Trazodone—Hypersensitivity—Bleomycin—skin cancer	0.000258	0.00137	CcSEcCtD
Trazodone—Decreased appetite—Temozolomide—skin cancer	0.000257	0.00137	CcSEcCtD
Trazodone—Flushing—Docetaxel—skin cancer	0.000257	0.00137	CcSEcCtD
Trazodone—Fatigue—Temozolomide—skin cancer	0.000255	0.00136	CcSEcCtD
Trazodone—Hypotension—Fluorouracil—skin cancer	0.000254	0.00136	CcSEcCtD
Trazodone—Pain—Temozolomide—skin cancer	0.000253	0.00135	CcSEcCtD
Trazodone—Constipation—Temozolomide—skin cancer	0.000253	0.00135	CcSEcCtD
Trazodone—ORM1—lymph node—skin cancer	0.000251	0.0141	CbGeAlD
Trazodone—Asthenia—Bleomycin—skin cancer	0.000251	0.00134	CcSEcCtD
Trazodone—ADRA1A—head—skin cancer	0.00025	0.0141	CbGeAlD
Trazodone—Chills—Docetaxel—skin cancer	0.000248	0.00132	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000248	0.00132	CcSEcCtD
Trazodone—Pruritus—Bleomycin—skin cancer	0.000248	0.00132	CcSEcCtD
Trazodone—Arrhythmia—Docetaxel—skin cancer	0.000247	0.00132	CcSEcCtD
Trazodone—Insomnia—Fluorouracil—skin cancer	0.000246	0.00131	CcSEcCtD
Trazodone—Paraesthesia—Fluorouracil—skin cancer	0.000244	0.0013	CcSEcCtD
Trazodone—Alopecia—Docetaxel—skin cancer	0.000244	0.0013	CcSEcCtD
Trazodone—Feeling abnormal—Temozolomide—skin cancer	0.000243	0.0013	CcSEcCtD
Trazodone—Dyspnoea—Fluorouracil—skin cancer	0.000243	0.00129	CcSEcCtD
Trazodone—Somnolence—Fluorouracil—skin cancer	0.000242	0.00129	CcSEcCtD
Trazodone—Gastrointestinal pain—Temozolomide—skin cancer	0.000241	0.00129	CcSEcCtD
Trazodone—Hypersensitivity—Dactinomycin—skin cancer	0.000241	0.00128	CcSEcCtD
Trazodone—Decreased appetite—Fluorouracil—skin cancer	0.000237	0.00126	CcSEcCtD
Trazodone—Dysgeusia—Docetaxel—skin cancer	0.000236	0.00126	CcSEcCtD
Trazodone—Urticaria—Temozolomide—skin cancer	0.000235	0.00125	CcSEcCtD
Trazodone—Asthenia—Dactinomycin—skin cancer	0.000234	0.00125	CcSEcCtD
Trazodone—Abdominal pain—Temozolomide—skin cancer	0.000233	0.00124	CcSEcCtD
Trazodone—Body temperature increased—Temozolomide—skin cancer	0.000233	0.00124	CcSEcCtD
Trazodone—Back pain—Docetaxel—skin cancer	0.000233	0.00124	CcSEcCtD
Trazodone—Pain—Fluorouracil—skin cancer	0.000233	0.00124	CcSEcCtD
Trazodone—HRH1—female reproductive system—skin cancer	0.000232	0.013	CbGeAlD
Trazodone—ADRA2A—female reproductive system—skin cancer	0.000228	0.0128	CbGeAlD
Trazodone—Feeling abnormal—Fluorouracil—skin cancer	0.000224	0.0012	CcSEcCtD
Trazodone—Diarrhoea—Dactinomycin—skin cancer	0.000223	0.00119	CcSEcCtD
Trazodone—Vomiting—Bleomycin—skin cancer	0.000223	0.00119	CcSEcCtD
Trazodone—Anaemia—Docetaxel—skin cancer	0.000222	0.00119	CcSEcCtD
Trazodone—Rash—Bleomycin—skin cancer	0.000221	0.00118	CcSEcCtD
Trazodone—Dermatitis—Bleomycin—skin cancer	0.000221	0.00118	CcSEcCtD
Trazodone—Hypersensitivity—Temozolomide—skin cancer	0.000218	0.00116	CcSEcCtD
Trazodone—Urticaria—Fluorouracil—skin cancer	0.000216	0.00115	CcSEcCtD
Trazodone—Syncope—Docetaxel—skin cancer	0.000216	0.00115	CcSEcCtD
Trazodone—Body temperature increased—Fluorouracil—skin cancer	0.000215	0.00115	CcSEcCtD
Trazodone—Palpitations—Docetaxel—skin cancer	0.000213	0.00113	CcSEcCtD
Trazodone—HTR2B—lymph node—skin cancer	0.000212	0.0119	CbGeAlD
Trazodone—Asthenia—Temozolomide—skin cancer	0.000212	0.00113	CcSEcCtD
Trazodone—Loss of consciousness—Docetaxel—skin cancer	0.000211	0.00113	CcSEcCtD
Trazodone—Pruritus—Temozolomide—skin cancer	0.000209	0.00111	CcSEcCtD
Trazodone—Nausea—Bleomycin—skin cancer	0.000208	0.00111	CcSEcCtD
Trazodone—Hypertension—Docetaxel—skin cancer	0.000208	0.00111	CcSEcCtD
Trazodone—Vomiting—Dactinomycin—skin cancer	0.000208	0.00111	CcSEcCtD
Trazodone—Rash—Dactinomycin—skin cancer	0.000206	0.0011	CcSEcCtD
Trazodone—Myalgia—Docetaxel—skin cancer	0.000205	0.00109	CcSEcCtD
Trazodone—Chest pain—Docetaxel—skin cancer	0.000205	0.00109	CcSEcCtD
Trazodone—Arthralgia—Docetaxel—skin cancer	0.000205	0.00109	CcSEcCtD
Trazodone—Diarrhoea—Temozolomide—skin cancer	0.000202	0.00108	CcSEcCtD
Trazodone—Hypersensitivity—Fluorouracil—skin cancer	0.0002	0.00107	CcSEcCtD
Trazodone—Dry mouth—Docetaxel—skin cancer	0.0002	0.00107	CcSEcCtD
Trazodone—Confusional state—Docetaxel—skin cancer	0.000198	0.00106	CcSEcCtD
Trazodone—Oedema—Docetaxel—skin cancer	0.000196	0.00105	CcSEcCtD
Trazodone—Dizziness—Temozolomide—skin cancer	0.000195	0.00104	CcSEcCtD
Trazodone—Nausea—Dactinomycin—skin cancer	0.000194	0.00103	CcSEcCtD
Trazodone—HRH1—head—skin cancer	0.000194	0.0109	CbGeAlD
Trazodone—HTR2A—female reproductive system—skin cancer	0.000194	0.0109	CbGeAlD
Trazodone—Shock—Docetaxel—skin cancer	0.000193	0.00103	CcSEcCtD
Trazodone—Pruritus—Fluorouracil—skin cancer	0.000192	0.00103	CcSEcCtD
Trazodone—Tachycardia—Docetaxel—skin cancer	0.000192	0.00102	CcSEcCtD
Trazodone—ADRA2A—head—skin cancer	0.00019	0.0107	CbGeAlD
Trazodone—Vomiting—Temozolomide—skin cancer	0.000188	0.001	CcSEcCtD
Trazodone—Anorexia—Docetaxel—skin cancer	0.000187	0.000998	CcSEcCtD
Trazodone—Rash—Temozolomide—skin cancer	0.000186	0.000993	CcSEcCtD
Trazodone—Diarrhoea—Fluorouracil—skin cancer	0.000186	0.000992	CcSEcCtD
Trazodone—Dermatitis—Temozolomide—skin cancer	0.000186	0.000992	CcSEcCtD
Trazodone—Headache—Temozolomide—skin cancer	0.000185	0.000986	CcSEcCtD
Trazodone—Hypotension—Docetaxel—skin cancer	0.000183	0.000978	CcSEcCtD
Trazodone—Dizziness—Fluorouracil—skin cancer	0.00018	0.000959	CcSEcCtD
Trazodone—CYP3A4—female reproductive system—skin cancer	0.000179	0.0101	CbGeAlD
Trazodone—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000179	0.000954	CcSEcCtD
Trazodone—Insomnia—Docetaxel—skin cancer	0.000178	0.000947	CcSEcCtD
Trazodone—CYP2D6—female reproductive system—skin cancer	0.000176	0.00992	CbGeAlD
Trazodone—Paraesthesia—Docetaxel—skin cancer	0.000176	0.00094	CcSEcCtD
Trazodone—Nausea—Temozolomide—skin cancer	0.000175	0.000935	CcSEcCtD
Trazodone—Dyspnoea—Docetaxel—skin cancer	0.000175	0.000933	CcSEcCtD
Trazodone—Somnolence—Docetaxel—skin cancer	0.000175	0.000931	CcSEcCtD
Trazodone—Vomiting—Fluorouracil—skin cancer	0.000173	0.000922	CcSEcCtD
Trazodone—Rash—Fluorouracil—skin cancer	0.000172	0.000914	CcSEcCtD
Trazodone—Dermatitis—Fluorouracil—skin cancer	0.000171	0.000914	CcSEcCtD
Trazodone—ABCB1—epithelium—skin cancer	0.000171	0.0096	CbGeAlD
Trazodone—Decreased appetite—Docetaxel—skin cancer	0.000171	0.00091	CcSEcCtD
Trazodone—Headache—Fluorouracil—skin cancer	0.00017	0.000909	CcSEcCtD
Trazodone—Fatigue—Docetaxel—skin cancer	0.000169	0.000903	CcSEcCtD
Trazodone—Constipation—Docetaxel—skin cancer	0.000168	0.000895	CcSEcCtD
Trazodone—Pain—Docetaxel—skin cancer	0.000168	0.000895	CcSEcCtD
Trazodone—Feeling abnormal—Docetaxel—skin cancer	0.000162	0.000863	CcSEcCtD
Trazodone—HTR2A—head—skin cancer	0.000162	0.00909	CbGeAlD
Trazodone—Nausea—Fluorouracil—skin cancer	0.000162	0.000862	CcSEcCtD
Trazodone—Gastrointestinal pain—Docetaxel—skin cancer	0.000161	0.000856	CcSEcCtD
Trazodone—Abdominal pain—Docetaxel—skin cancer	0.000155	0.000828	CcSEcCtD
Trazodone—Body temperature increased—Docetaxel—skin cancer	0.000155	0.000828	CcSEcCtD
Trazodone—ABCB1—mammalian vulva—skin cancer	0.000148	0.00833	CbGeAlD
Trazodone—CYP2D6—head—skin cancer	0.000147	0.00829	CbGeAlD
Trazodone—Hypersensitivity—Docetaxel—skin cancer	0.000145	0.000771	CcSEcCtD
Trazodone—Asthenia—Docetaxel—skin cancer	0.000141	0.000751	CcSEcCtD
Trazodone—Pruritus—Docetaxel—skin cancer	0.000139	0.000741	CcSEcCtD
Trazodone—HRH1—lymph node—skin cancer	0.000136	0.00762	CbGeAlD
Trazodone—Diarrhoea—Docetaxel—skin cancer	0.000134	0.000716	CcSEcCtD
Trazodone—ADRA2A—lymph node—skin cancer	0.000133	0.00749	CbGeAlD
Trazodone—ABCB1—lymphoid tissue—skin cancer	0.000132	0.0074	CbGeAlD
Trazodone—Dizziness—Docetaxel—skin cancer	0.00013	0.000692	CcSEcCtD
Trazodone—ABCB1—female reproductive system—skin cancer	0.000127	0.00713	CbGeAlD
Trazodone—Vomiting—Docetaxel—skin cancer	0.000125	0.000666	CcSEcCtD
Trazodone—Rash—Docetaxel—skin cancer	0.000124	0.00066	CcSEcCtD
Trazodone—Dermatitis—Docetaxel—skin cancer	0.000124	0.000659	CcSEcCtD
Trazodone—Headache—Docetaxel—skin cancer	0.000123	0.000656	CcSEcCtD
Trazodone—Nausea—Docetaxel—skin cancer	0.000117	0.000622	CcSEcCtD
Trazodone—ABCB1—head—skin cancer	0.000106	0.00596	CbGeAlD
Trazodone—ABCB1—lymph node—skin cancer	7.42e-05	0.00417	CbGeAlD
